{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:04:12Z","timestamp":1792785852024,"version":"4.5.0"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Unit of Nephrology and the Clinical Research Center"},{"name":"European Reference Network for Rare Kidney Diseases","id":[{"id":"https:\/\/ror.org\/04x2ddb07","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The performance of serum-creatinine- and\/or cystatin-C-based chronic kidney disease -Epidemiology (CKD-Epi) Collaboration and European Kidney Function Consortium (EKFC) glomerular filtration rate (GFR) estimates (creatinine-based GFR estimates (eGFRcr), cystatin-C-based GFR estimates (eGFRcys), and eGFRcr + cys, respectively) in nephrotic patients with CKD is unknown.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively evaluated the performance of all the six aforementioned equations in 100 blood samples collected 1-year apart from 50 consenting patients with primary membranous nephropathy (MN) and proteinuria &amp;gt;3.5 g\/24 h who had their GFR simultaneously measured with the iohexol plasma clearance technique during three intervention studies. The study had &amp;gt;85% power to detect a significant difference between actual and reference (0.90) concordance correlation coefficient (CCC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>With CKD-Epi and EKFC, eGFRcr values overestimated, whereas eGFRcys values underestimated (P &amp;lt; 0.001 for all) measured GFR (mGFR). eGFRcr + cys bias was significant (P &amp;lt; 0.05) in hypo-albuminemic participants. Biases significantly increased with worsening hypoalbuminemia, but independently of proteinuria. In normo-albuminemic participants, CCC did not differ from the 0.90 reference value and total deviation index (TDI) was &amp;lt;30 only with CKD-Epi and EKFC eGFRcr + cys equations. The error exceeded 10% in &amp;gt;40% of estimates. Over one year, mGFR increased by 4.8 ml\/min\/1.73 m2 (P = 0.008). This change was not captured by any equation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The performance of GFR estimation equations is acceptable only when creatinine and cystatin-C are simultaneously used as filtration markers in nephrotic patients without hypoalbuminemia. Direct GFR measurement is needed for accurate kidney function evaluation in those with hypoalbuminemia, and whenever individual clinical decision makings (including dosing of toxic medications with renal clearance) or evaluations of treatment effects on GFR changes over time are needed in clinics or research.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ckj\/sfag256","type":"journal-article","created":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T13:10:58Z","timestamp":1788181858000},"source":"Crossref","is-referenced-by-count":0,"title":["Glomerular filtration rate estimation in nephrotic patients: creatinine and\/or cystatin-C-based equations, or none of them?"],"prefix":"10.1093","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-4175-847X","authenticated-orcid":false,"given":"Fabiola","family":"Carrara","sequence":"first","affiliation":[{"name":"Istituto di Ricerche Farmacologiche Mario Negri IRCCS , Bergamo ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serenella","family":"Valaperta","sequence":"additional","affiliation":[{"name":"Unit of Laboratory Medicine and Clinical Chemistry , Bergamo ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariagrazia","family":"Alessio","sequence":"additional","affiliation":[{"name":"Unit of Laboratory Medicine and Clinical Chemistry , Bergamo ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1859-1729","authenticated-orcid":false,"given":"Matias","family":"Trillini","sequence":"additional","affiliation":[{"name":"Istituto di Ricerche Farmacologiche Mario Negri IRCCS , Bergamo ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Gennarini","sequence":"additional","affiliation":[{"name":"Unit of Nephrology, Azienda Socio-Sanitaria Territoriale (ASST) Papa Giovanni XXIII , Bergamo ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aura","family":"Crispino","sequence":"additional","affiliation":[{"name":"Istituto di Ricerche Farmacologiche Mario Negri IRCCS , Bergamo ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Villa","sequence":"additional","affiliation":[{"name":"Istituto di Ricerche Farmacologiche Mario Negri IRCCS , Bergamo ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobia","family":"Peracchi","sequence":"additional","affiliation":[{"name":"Istituto di Ricerche Farmacologiche Mario Negri IRCCS , Bergamo ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Cugini","sequence":"additional","affiliation":[{"name":"Istituto di Ricerche Farmacologiche Mario Negri IRCCS , Bergamo ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Stucchi","sequence":"additional","affiliation":[{"name":"Istituto di Ricerche Farmacologiche Mario Negri IRCCS , Bergamo ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Pagani","sequence":"additional","affiliation":[{"name":"Istituto di Ricerche Farmacologiche Mario Negri IRCCS , Bergamo ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Remuzzi","sequence":"additional","affiliation":[{"name":"Istituto di Ricerche Farmacologiche Mario Negri IRCCS , Bergamo ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8394-0879","authenticated-orcid":false,"given":"Piero","family":"Ruggenenti","sequence":"additional","affiliation":[{"name":"Istituto di Ricerche Farmacologiche Mario Negri IRCCS , Bergamo ,","place":["Italy"]},{"name":"Unit of Nephrology, Azienda Socio-Sanitaria Territoriale (ASST) Papa Giovanni XXIII , Bergamo ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,8,31]]},"reference":[{"key":"2026092605162792100_bib1","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"2026092605162792100_bib2","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1681\/ASN.0000000000000227","article-title":"CKD-EPI and EKFC GFR estimating equations: performance and other considerations for selecting equations for implementation in adults","volume":"34","author":"Inker","year":"2023","journal-title":"J Am Soc Nephrol"},{"key":"2026092605162792100_bib3","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","article-title":"New Creatinine- and Cystatin C\u2013based equations to estimate GFR without race","volume":"385","author":"Inker","year":"2021","journal-title":"N Engl J Med"},{"key":"2026092605162792100_bib4","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","article-title":"KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"105","author":"Stevens","year":"2024","journal-title":"Kidney Int"},{"key":"2026092605162792100_bib5","doi-asserted-by":"publisher","first-page":"183","DOI":"10.7326\/M20-4366","article-title":"Development and validation of a modified full age spectrum creatinine-based equation to estimate glomerular filtration rate: a cross-sectional analysis of pooled data","volume":"174","author":"Pottel","year":"2021","journal-title":"Ann Intern Med"},{"key":"2026092605162792100_bib6","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1056\/NEJMoa2203769","article-title":"Cystatin C\u2013based equation to estimate GFR without the inclusion of race and sex","volume":"388","author":"Pottel","year":"2023","journal-title":"N Engl J Med"},{"key":"2026092605162792100_bib7","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/s41581-018-0080-9","article-title":"Estimated GFR: time for a critical appraisal","volume":"15","author":"Porrini","year":"2018","journal-title":"Nat Rev Nephrol"},{"key":"2026092605162792100_bib8","doi-asserted-by":"publisher","first-page":"178","DOI":"10.2215\/CJN.0000000602","article-title":"Reliability of GFR estimated by creatinine-based formulas in moderate-to-severe proteinuria","volume":"20","author":"Zoccali","year":"2025"},{"key":"2026092605162792100_bib9","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/nrneph.2012.42","article-title":"Proteinuria should be used as a surrogate in CKD","volume":"8","author":"Cravedi","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"2026092605162792100_bib10","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1053\/j.ajkd.2009.04.029","article-title":"Proteinuria as a surrogate outcome in CKD: report of a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration","volume":"54","author":"Levey","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"2026092605162792100_bib11","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1111\/j.1523-1755.2004.00653.x","article-title":"Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL","volume":"65","author":"De\u00a0Zeeuw","year":"2004","journal-title":"Kidney Int"},{"key":"2026092605162792100_bib12","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1002\/jcla.21513","article-title":"Risk of Overestimation of kidney function using gfr -estimating equations in patients with low inulin clearance","volume":"26","author":"Nakata","year":"2012","journal-title":"Clinical Laboratory Analysis"},{"key":"2026092605162792100_bib13","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0002-9343(80)90376-9","article-title":"Creatinine: an inadequate filtration marker in glomerular diseases","volume":"69","author":"Carrie","year":"1980","journal-title":"Am J Med"},{"key":"2026092605162792100_bib14","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1111\/apa.12993","article-title":"Estimated glomerular filtration rates cannot replace measured gfr in type 1 diabetes patients with hyperfiltration","volume":"104","author":"Perrin","year":"2015","journal-title":"Acta Paediatr"},{"key":"2026092605162792100_bib15","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/ki.2013.47","article-title":"The GFR and GFR decline cannot be accurately estimated in type 2 diabetics","volume":"84","author":"Gaspari","year":"2013","journal-title":"Kidney Int"},{"key":"2026092605162792100_bib16","doi-asserted-by":"publisher","first-page":"e14278","DOI":"10.1111\/eci.14278","article-title":"Which is the best glomerular filtration marker: creatinine, cystatin C or both?","volume":"54","author":"Stehl\u00e9","year":"2024","journal-title":"Eur J Clin Invest"},{"key":"2026092605162792100_bib17","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1016\/S0140-6736(98)04433-X","article-title":"Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial","volume":"352","author":"Ruggenenti","year":"1998","journal-title":"Lancet"},{"key":"2026092605162792100_bib18","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S0140-6736(05)71082-5","article-title":"Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomized controlled trial","volume":"365","author":"Ruggenenti","year":"2005","journal-title":"Lancet"},{"key":"2026092605162792100_bib19","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1681\/ASN.V62257","article-title":"Plasma clearance of nonradioactive iohexol as a measure of glomerular filtration rate","volume":"6","author":"Gaspari","year":"1995","journal-title":"J Am Soc Nephrol"},{"key":"2026092605162792100_bib20","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1590\/2175-8239-jbn-2019-0240","article-title":"Cystatin C: not just a marker of kidney function","volume":"42","author":"Fernando","year":"2020","journal-title":"Braz J Nephrol"},{"key":"2026092605162792100_bib21","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1515\/CCLM.2008.336","article-title":"Cystatin C: current position and future prospects","volume":"46","author":"S\u00e9ronie-Vivien","year":"2008","journal-title":"Clin Chem Lab Med"},{"key":"2026092605162792100_bib22","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1053\/j.ajkd.2013.03.027","article-title":"Update on cystatin C: incorporation into clinical practice","volume":"62","author":"Shlipak","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"2026092605162792100_bib23","doi-asserted-by":"publisher","first-page":"586","DOI":"10.7326\/0003-4819-142-7-200504050-00016","article-title":"Estimates of kidney function: searching for better measures of kidney function and cardiovascular risk","volume":"142","author":"C","year":"2005","journal-title":"Ann Intern Med"},{"key":"2026092605162792100_bib24","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1093\/ndt\/gfad219","article-title":"Accuracy of GFR estimating equations based on creatinine, cystatin C or both in routine care","volume":"39","author":"Fu","year":"2024","journal-title":"Nephrol Dial Transplant"},{"key":"2026092605162792100_bib25","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1681\/ASN.2010050483","article-title":"Cystatin C identifies chronic kidney disease patients at higher risk for complications","volume":"22","author":"Peralta","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"2026092605162792100_bib26","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1056\/NEJMoa1114248","article-title":"Estimating glomerular filtration rate from serum creatinine and cystatin C","volume":"367","author":"Inker","year":"2012","journal-title":"N Engl J Med"},{"key":"2026092605162792100_bib27","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1053\/ajkd.2002.34487","article-title":"Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis","volume":"40","author":"Dharnidharka","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"2026092605162792100_bib28","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1093\/clinchem\/46.8.1206","article-title":"Plasma cystatin C is superior to 24-h creatinine clearance and plasma creatinine for estimation of glomerular filtration rate 3 months after kidney transplantation","volume":"46","author":"Le\u00a0Bricon","year":"2000","journal-title":"Clin Chem"},{"key":"2026092605162792100_bib29","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s12882-015-0188-0","article-title":"The chronic kidney disease epidemiology collaboration equation combining creatinine and cystatin C accurately assesses renal function in patients with cirrhosis","volume":"16","author":"Krones","year":"2015","journal-title":"BMC Nephrol"},{"key":"2026092605162792100_bib30","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ejim.2020.04.044","article-title":"Comparison of bias and accuracy using cystatin C and creatinine in CKD-EPI equations for GFR estimation","volume":"80","author":"Zou","year":"2020","journal-title":"Eur J Intern Med"},{"key":"2026092605162792100_bib31","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1093\/clinchem\/hvaa237","article-title":"Long-term longitudinal stability of kidney filtration marker measurements: implications for epidemiological studies and clinical care","volume":"67","author":"Karger","year":"2021","journal-title":"Clin Chem"},{"key":"2026092605162792100_bib32","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3343\/alm.2023.0237","article-title":"Exploring renal function assessment: creatinine, Cystatin C, and estimated glomerular filtration rate focused on the European Kidney Function Consortium Equation","volume":"44","author":"Pottel","year":"2024","journal-title":"Ann Lab Med"},{"key":"2026092605162792100_bib33","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1515\/cclm-2018-1175","article-title":"Accuracy of determination of the glomerular filtration marker iohexol by European laboratories as monitored by external quality assessment","volume":"57","author":"Nordin","year":"2019","journal-title":"Clin Chem Lab Med"},{"key":"2026092605162792100_bib34","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3109\/00365517209084290","article-title":"A Simple Method for the determination of glomerular filtration rate","volume":"30","author":"Br\u00f6chner-Mortensen","year":"1972","journal-title":"Scand J Clin Lab Invest"},{"key":"2026092605162792100_bib35","first-page":"303","article-title":"A formula to estimate the approximate surface area if height and weight be known","volume":"5","author":"Du\u00a0Bois","year":"1989","journal-title":"Nutrition"},{"key":"2026092605162792100_bib36","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s12874-020-01022-x","article-title":"Using multiple agreement methods for continuous repeated measures data: a tutorial for practitioners","volume":"20","author":"Parker","year":"2020","journal-title":"BMC Med Res Methodol"},{"key":"2026092605162792100_bib37","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4614-0562-7","volume-title":"Statistical tools for measuring agreement","author":"Lin","year":"2012"},{"key":"2026092605162792100_bib38","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1198\/016214502753479392","article-title":"Statistical methods in assessing agreement: models, issues, and tools","volume":"97","author":"Lin","year":"2002","journal-title":"J Am Statist Assoc"},{"key":"2026092605162792100_bib39","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1111\/j.2041-210x.2012.00261.x","article-title":"A general and simple method for obtaining R2 from generalized linear mixed-effects models","volume":"4","author":"Nakagawa","year":"2013","journal-title":"Methods Ecol Evol"},{"key":"2026092605162792100_bib40","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1681\/ASN.V92310","article-title":"Precision of plasma clearance of iohexol for estimation of GFR in patients with renal disease","volume":"9","author":"Gaspari","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"2026092605162792100_bib41","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0140-6736(86)90837-8","article-title":"Statistical methods for assessing agreement between two methods of clinical measurement","volume":"327","author":"Martin\u00a0Bland","year":"1986","journal-title":"Lancet"},{"key":"2026092605162792100_bib42","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1177\/0284185180021362S20","article-title":"Biochemical-pharmacologic properties of iohexol","volume":"362","author":"M\u00fctzel","year":"1980","journal-title":"Acta Radiol Suppl"},{"key":"2026092605162792100_bib43","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1053\/j.ajkd.2020.09.017","article-title":"Tubular secretion of creatinine and risk of kidney failure: the modification of diet in renal disease (MDRD) study","volume":"77","author":"Garimella","year":"2021","journal-title":"Am J Kidney Dis"},{"key":"2026092605162792100_bib44","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1093\/ndt\/gfh719","article-title":"Serum creatinine is a poor marker of GFR in nephrotic syndrome","volume":"20","author":"Branten","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"2026092605162792100_bib45","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1093\/ndt\/gfq443","article-title":"Estimated glomerular filtration rate in the nephrotic syndrome","volume":"26","author":"Hofstra","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"2026092605162792100_bib46","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/S0272-6386(12)70137-3","article-title":"Edema of the nephrotic syndrome: the role of the atrial peptide system","volume":"22","author":"Perico","year":"1993","journal-title":"Am J Kidney Dis"},{"key":"2026092605162792100_bib47","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1007\/s00467-013-2435-6","article-title":"Over- or underfill: not all nephrotic states are created equal","volume":"28","author":"Bockenhauer","year":"2013","journal-title":"Pediatr Nephrol"},{"key":"2026092605162792100_bib48","doi-asserted-by":"publisher","first-page":"688","DOI":"10.7326\/0003-4819-91-5-688","article-title":"Nephrotic Syndrome: vasoconstriction and hypervolemic types indicated by renin-sodium profiling","volume":"91","author":"Meltzer","year":"1979","journal-title":"Ann Intern Med"},{"key":"2026092605162792100_bib49","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1093\/ckj\/sfad039","article-title":"New and old GFR equations: a European perspective","volume":"16","author":"Delanaye","year":"2023","journal-title":"Clin Kidney J"},{"key":"2026092605162792100_bib50","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/s12882-024-03632-9","article-title":"Nephrotic syndrome associated with solid malignancies: a systematic review","volume":"25","author":"Liu","year":"2024","journal-title":"BMC Nephrol"}],"container-title":["Clinical Kidney Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ckj\/advance-article-pdf\/doi\/10.1093\/ckj\/sfag256\/70881927\/sfag256.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/19\/9\/sfag256\/70881927\/sfag256.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/19\/9\/sfag256\/70881927\/sfag256.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T09:16:35Z","timestamp":1790414195000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ckj\/article\/doi\/10.1093\/ckj\/sfag256\/8776674"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,31]]},"references-count":50,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ckj\/sfag256","relation":{},"ISSN":["2048-8505","2048-8513"],"issn-type":[{"value":"2048-8505","type":"print"},{"value":"2048-8513","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9]]},"published":{"date-parts":[[2026,8,31]]},"article-number":"sfag256"}}